Are mutations in the IDH2 gene suitable molecular markers for MRD monitoring in AML patienst?

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.

Authors	JEŽÍŠKOVÁ Ivana RÁZGA Filip DVOŘÁKOVÁ Dana SEMERÁD Lukáš SUSTKOVA Z. MAYER Jiří RÁČIL Zdeněk
Year of publication	2013
Type	Conference abstract
MU Faculty or unit	Central European Institute of Technology
Citation
Related projects:	Functional and molecular characteristics of cancer and normal stem cells - identification of targets for novel therapeutics and therapeutic strategies